Toll Free: 1-888-928-9744

Global Endometriosis Drugs Market Research Report 2021

Published: Jul, 2016 | Pages: 130 | Publisher: QYResearch
Industry: Pharmaceutical | Report Format: Electronic (PDF)

This report studies Endometriosis Drugs in Global market, especially in North America, Europe, China, Japan, India and Southeast Asia, focuses on top manufacturers in global market, with sales, price, revenue and market share for each manufacturer, covering
    AbbVie
    AstraZeneca
    Bayer HealthCare
    Pfizer
    Addex Therapeutics
    Astellas Pharma
    Debiopharm
    ElexoPharm
    Endoceutics
    Euroscreen
    Forendo Pharma
    Isifer
    Kissei Pharmaceutical
    Neurocrine Biosciences
    Nippon Shinyaku
    ObsEva
    Orphagen Pharmaceuticals
    Philogen
    PregLem
    Repros Therapeutics
    Roivant Sciences
    SK Chemicals
    Speciality European Pharma
    SYNG Pharmaceuticals
    Takeda
    United Pharmaceuticals
    ValiPharma
Market Segment by Region, this report splits Global into several key Regions, with sales, revenue, market share and growth rate of Endometriosis Drugs in these regions, from 2011 to 2021 (forecast), like
    North America
    China
    Europe
    Japan
    India
    Southeast Asia
Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
    Oral
    Parenteral
    Intrauterine Systems
    Nasal Spray
Split by application, this report focuses on sales, market share and growth rate of Endometriosis Drugs in each application, can be divided into
    Application 1
    Application 2
    Application 3

 Table of Contents
Global Endometriosis Drugs Market Research Report 2021 1 Endometriosis Drugs Overview 1.1 Product Overview and Scope of Endometriosis Drugs 1.2 Endometriosis Drugs Segment by Types 1.2.1 Global Sales Market Share of Endometriosis Drugs by Type in 2015 1.2.2 Oral 1.2.3 Parenteral 1.2.4 Intrauterine Systems 1.2.5 Nasal Spray 1.3 Endometriosis Drugs Segment by Applications 1.3.1 Application 1 1.3.2 Application 2 1.3.3 Application 3 1.4 Endometriosis Drugs Market by Regions 1.4.1 North America Status and Prospect (2011-2021) 1.4.2 China Status and Prospect (2011-2021) 1.4.3 Europe Status and Prospect (2011-2021) 1.4.4 Japan Status and Prospect (2011-2021) 1.4.5 India Status and Prospect (2011-2021) 1.4.6 Southeast Asia Status and Prospect (2011-2021) 1.5 Global Market Size (Value and Volume) of Endometriosis Drugs (2011-2021) 1.5.1 Global Endometriosis Drugs Sales and Revenue (2011-2021) 1.5.2 Global Endometriosis Drugs Sales and Growth Rate (2011-2021) 1.5.3 Global Endometriosis Drugs Revenue and Growth Rate (2011-2021) 2 Global Endometriosis Drugs Market Competition by Manufacturers 2.1 Global Endometriosis Drugs Sales and Share by Manufacturers (2015 and 2016) 2.2 Global Endometriosis Drugs Revenue and Share by Manufacturers (2015 and 2016) 2.3 Manufacturers Endometriosis Drugs Manufacturing Base Distribution and Product Type 2.4 Competitive Situation and Trends 2.4.1 Expansions 2.4.2 New Product Launches 2.4.3 Acquisitions 2.4.4 Other Developments 3 Global Endometriosis Drugs Analysis by Region 3.1 Global Endometriosis Drugs Sales, Revenue and Market Share by Region (2011-2021) 3.1.1 Global Endometriosis Drugs Sales Market Share by Region (2011-2021) 3.1.2 Global Endometriosis Drugs Revenue Market Share by Region (2011-2021) 3.2 North America 3.2.1 North America Endometriosis Drugs Sales, Revenue and Price (2011-2021) 3.2.2 North America Endometriosis Drugs Sales, Revenue and Growth Rate (2011-2021) 3.3 Europe 3.3.1 Europe Endometriosis Drugs Sales, Revenue and Price (2011-2021) 3.3.2 Europe Endometriosis Drugs Sales, Revenue and Growth Rate (2011-2021) 3.4 China 3.4.1 China Endometriosis Drugs Sales, Revenue and Price (2011-2021) 3.4.2 China Endometriosis Drugs Sales, Revenue and Growth Rate (2011-2021) 3.5 Japan 3.5.1 Japan Endometriosis Drugs Sales, Revenue and Price (2011-2021) 3.5.2 Japan Endometriosis Drugs Sales, Revenue and Growth Rate (2011-2021) 3.6 India 3.6.1 India Endometriosis Drugs Sales, Revenue and Price (2011-2021) 3.6.2 India Endometriosis Drugs Sales, Revenue and Growth Rate (2011-2021) 3.7 Southeast Asia 3.7.1 Southeast Asia Endometriosis Drugs Sales, Revenue and Price (2011-2021) 3.7.2 Southeast Asia Endometriosis Drugs Sales, Revenue and Growth Rate (2011-2021) 4 Global Endometriosis Drugs Analysis by Type 4.1 Global Endometriosis Drugs Sales, Revenue, Market Share and Growth Rate by Type (2011-2021) 4.1.1 Global Endometriosis Drugs Sales and Market Share by Type (2011-2021) 4.1.2 Global Endometriosis Drugs Revenue, Market Share and Growth Rate by Type (2011-2021) 4.2 Oral Sales, Revenue, Price and Growth (2011-2021) 4.3 Parenteral Sales, Revenue, Price and Growth (2011-2021) 4.4 Intrauterine Systems Sales, Revenue, Price and Growth (2011-2021) 4.5 Nasal Spray Sales, Revenue, Price and Growth (2011-2021) 5 Global Endometriosis Drugs Market Analysis by Application 5.1 Global Endometriosis Drugs Sales and Market Share by Application (2011-2021) 5.2 Major Regions Endometriosis Drugs Sales by Application in 2015 and 2016 5.2.1 North America Endometriosis Drugs Sales by Application 5.2.2 Europe Endometriosis Drugs Sales by Application 5.2.3 China Endometriosis Drugs Sales by Application 5.2.4 Japan Endometriosis Drugs Sales by Application 5.2.5 India Endometriosis Drugs Sales by Application 5.2.6 Southeast Asia Endometriosis Drugs Sales by Application 6 Global Endometriosis Drugs Manufacturers Analysis 6.1 AbbVie 6.1.1 Company Basic Information, Manufacturing Base and Competitors 6.1.2 Endometriosis Drugs Product Overview 6.1.2.1 Oral 6.1.2.2 Parenteral 6.1.2.3 Intrauterine Systems 6.1.3 Endometriosis Drugs Sales, Revenue, Price of AbbVie (2015 and 2016) 6.2 AstraZeneca 6.2.1 Company Basic Information, Manufacturing Base and Competitors 6.2.2 Endometriosis Drugs Product Overview 6.2.2.1 Oral 6.2.2.2 Parenteral 6.2.2.3 Intrauterine Systems 6.2.3 Endometriosis Drugs Sales, Revenue, Price of AstraZeneca (2015 and 2016) 6.3 Bayer HealthCare 6.3.1 Company Basic Information, Manufacturing Base and Competitors 6.3.2 Endometriosis Drugs Product Overview 6.3.2.1 Oral 6.3.2.2 Parenteral 6.3.2.3 Intrauterine Systems 6.3.3 Endometriosis Drugs Sales, Revenue, Price of Bayer HealthCare (2015 and 2016) 6.4 Pfizer 6.4.1 Company Basic Information, Manufacturing Base and Competitors 6.4.2 Endometriosis Drugs Product Overview 6.4.2.1 Oral 6.4.2.2 Parenteral 6.4.3 Endometriosis Drugs Sales, Revenue, Price of Pfizer (2015 and 2016) 6.5 Addex Therapeutics 6.5.1 Company Basic Information, Manufacturing Base and Competitors 6.5.2 Endometriosis Drugs Product Overview 6.5.2.1 Oral 6.5.2.2 Parenteral 6.5.3 Endometriosis Drugs Sales, Revenue, Price of Addex Therapeutics (2015 and 2016) 6.6 Astellas Pharma 6.6.1 Company Basic Information, Manufacturing Base and Competitors 6.6.2 Endometriosis Drugs Product Overview 6.6.2.1 Oral 6.6.2.2 Parenteral 6.6.3 Endometriosis Drugs Sales, Revenue, Price of Astellas Pharma (2015 and 2016) 6.7 Debiopharm 6.7.1 Company Basic Information, Manufacturing Base and Competitors 6.7.2 Endometriosis Drugs Product Overview 6.7.2.1 Oral 6.7.2.2 Parenteral 6.7.3 Endometriosis Drugs Sales, Revenue, Price of Debiopharm (2015 and 2016) 6.8 ElexoPharm 6.8.1 Company Basic Information, Manufacturing Base and Competitors 6.8.2 Endometriosis Drugs Product Overview 6.8.2.1 Oral 6.8.2.2 Parenteral 6.8.3 Endometriosis Drugs Sales, Revenue, Price of ElexoPharm (2015 and 2016) 6.9 Endoceutics 6.9.1 Company Basic Information, Manufacturing Base and Competitors 6.9.2 Endometriosis Drugs Product Overview 6.9.2.1 Oral 6.9.2.2 Parenteral 6.9.3 Endometriosis Drugs Sales, Revenue, Price of Endoceutics (2015 and 2016) 6.10 Euroscreen 6.10.1 Company Basic Information, Manufacturing Base and Competitors 6.10.2 Endometriosis Drugs Product Overview 6.10.2.1 Oral 6.10.2.2 Parenteral 6.10.3 Endometriosis Drugs Sales, Revenue, Price of Euroscreen (2015 and 2016) 6.11 Forendo Pharma 6.12 Isifer 6.13 Kissei Pharmaceutical 6.14 Neurocrine Biosciences 6.15 Nippon Shinyaku 6.16 ObsEva 6.17 Orphagen Pharmaceuticals 6.18 Philogen 6.19 PregLem 6.20 Repros Therapeutics 6.21 Roivant Sciences 6.22 SK Chemicals 6.23 Speciality European Pharma 6.24 SYNG Pharmaceuticals 6.25 Takeda 6.26 United Pharmaceuticals 6.27 ValiPharma 7 Industry Policy Analysis 8 Research Findings and Conclusion
List of Tables and Figures
Figure Picture of Endometriosis Drugs Figure Global Sales Market Share of Endometriosis Drugs by Type in 2015 Table Endometriosis Drugs Product Type of by Manufacturers Table Endometriosis Drugs Sales Market Share by Application in 2015 and 2016 Figure North America Endometriosis Drugs Revenue and Growth Rate (2011-2021) Figure China Endometriosis Drugs Revenue and Growth Rate (2011-2021) Figure Europe Endometriosis Drugs Revenue and Growth Rate (2011-2021) Figure Japan Endometriosis Drugs Revenue and Growth Rate (2011-2021) Figure India Endometriosis Drugs Revenue and Growth Rate (2011-2021) Figure Southeast Asia Endometriosis Drugs Revenue and Growth Rate (2011-2021) Table Global Endometriosis Drugs Sales and Revenue (2011-2021) Figure Global Endometriosis Drugs Sales and Growth Rate (2011-2021) Figure Global Endometriosis Drugs Revenue and Growth Rate (2011-2021) Table Global Endometriosis Drugs Sales of Key Manufacturers (2015 and 2016) Table Global Endometriosis Drugs Sales Share by Manufacturers (2015 and 2016) Figure 2015 Endometriosis Drugs Sales Share by Manufacturers Figure 2016 Endometriosis Drugs Sales Share by Manufacturers Table Global Endometriosis Drugs Revenue by Manufacturers (2015 and 2016) Table Global Endometriosis Drugs Revenue Share by Manufacturers (2015 and 2016) Table 2015 Global Endometriosis Drugs Revenue Share by Manufacturers Table 2016 Global Endometriosis Drugs Revenue Share by Manufacturers Table Manufacturers Endometriosis Drugs Manufacturing Base Distribution and Product Type Table Global Endometriosis Drugs Sales Market by Region (2011-2021) Figure Global Endometriosis Drugs Sales Market by Region (2011-2021) Figure Global Endometriosis Drugs Sales Market Share by Region (2011-2021) Table Global Endometriosis Drugs Revenue Market by Region (2011-2021) Table Global Endometriosis Drugs Revenue Market Share by Region (2011-2021) Table North America Endometriosis Drugs Sales, Revenue and Price (2011-2021) Figure North America Endometriosis Drugs Sales, Revenue and Growth Rate (2011-2021) Table Europe Endometriosis Drugs Sales, Revenue and Price (2011-2021) Figure Europe Endometriosis Drugs Sales, Revenue and Growth Rate (2011-2021) Table China Endometriosis Drugs Sales, Revenue and Price (2011-2021) Figure China Endometriosis Drugs Sales, Revenue and Growth Rate (2011-2021) Table Japan Endometriosis Drugs Sales, Revenue and Price (2011-2021) Figure Japan Endometriosis Drugs Sales, Revenue and Growth Rate (2011-2021) Table India Endometriosis Drugs Sales, Revenue and Price (2011-2021) Figure India Endometriosis Drugs Sales, Revenue and Growth Rate (2011-2021) Table Southeast Asia Endometriosis Drugs Sales, Revenue and Price (2011-2021) Figure Southeast Asia Endometriosis Drugs Sales, Revenue and Growth Rate (2011-2021) Table Global Endometriosis Drugs Sales by Type (2011-2021) Table Global Endometriosis Drugs Sales Share by Type (2011-2021) Figure Sales Market Share of Endometriosis Drugs by Type (2011-2021) Figure Global Endometriosis Drugs Sales Growth Rate by Type (2011-2021) Table Global Endometriosis Drugs Revenue by Type (2011-2021) Table Global Endometriosis Drugs Revenue Share by Type (2011-2021) Figure Global Endometriosis Drugs Revenue Growth Rate by Type (2011-2021) Figure Oral Sales, Revenue and Growth (2011-2021) Figure Oral Price Trend (2011-2021) Figure Parenteral Sales, Revenue and Growth (2011-2021) Figure Parenteral Price Trend (2011-2021) Figure Intrauterine Systems Sales, Revenue and Growth (2011-2021) Figure Intrauterine Systems Price Trend (2011-2021) Figure Nasal Spray Sales, Revenue and Growth (2011-2021) Figure Nasal Spray Price Trend (2011-2021) Table Global Endometriosis Drugs Sales by Application (2011-2021) Table Global Endometriosis Drugs Sales Market Share by Application (2011-2021) Figure Global Endometriosis Drugs Sales Market Share by Application in 2015 Figure Global Endometriosis Drugs Sales Market Share by Application in 2021 Table North America Endometriosis Drugs Sales by Application (2015 and 2016) Table Europe Endometriosis Drugs Sales by Application (2015 and 2016) Table China Endometriosis Drugs Sales by Application (2015 and 2016) Table Japan Endometriosis Drugs Sales by Application (2015 and 2016) Table India Endometriosis Drugs Sales by Application (2015 and 2016) Table Southeast Asia Endometriosis Drugs Sales by Application (2015 and 2016) Table Global Endometriosis Drugs Sales Growth Rate by Application (2011-2021) Figure Global Endometriosis Drugs Sales Growth Rate by Application (2011-2021) Table AbbVie Basic Information List Table Endometriosis Drugs Sales, Revenue, Price of AbbVie (2015 and 2016) Table AstraZeneca Basic Information List Table Endometriosis Drugs Sales, Revenue, Price of AstraZeneca (2015 and 2016) Table Bayer HealthCare Basic Information List Table Endometriosis Drugs Sales, Revenue, Price of Bayer HealthCare (2015 and 2016) Table Pfizer Basic Information List Table Endometriosis Drugs Sales, Revenue, Price of Pfizer (2015 and 2016) Table Addex Therapeutics Basic Information List Table Endometriosis Drugs Sales, Revenue, Price of Addex Therapeutics (2015 and 2016) Table Astellas Pharma Basic Information List Table Endometriosis Drugs Sales, Revenue, Price of Astellas Pharma (2015 and 2016) Table Debiopharm Basic Information List Table Endometriosis Drugs Sales, Revenue, Price of Debiopharm (2015 and 2016) Table ElexoPharm Basic Information List Table Endometriosis Drugs Sales, Revenue, Price of ElexoPharm (2015 and 2016) Table Endoceutics Basic Information List Table Endometriosis Drugs Sales, Revenue, Price of Endoceutics (2015 and 2016) Table Euroscreen Basic Information List Table Endometriosis Drugs Sales, Revenue, Price of Euroscreen (2015 and 2016) Table Forendo Pharma Basic Information List Table Endometriosis Drugs Sales, Revenue, Price of Forendo Pharma (2015 and 2016) Table Isifer Basic Information List Table Endometriosis Drugs Sales, Revenue, Price of Isifer (2015 and 2016) Table Kissei Pharmaceutical Basic Information List Table Endometriosis Drugs Sales, Revenue, Price of Kissei Pharmaceutical (2015 and 2016) Table Neurocrine Biosciences Basic Information List Table Endometriosis Drugs Sales, Revenue, Price of Neurocrine Biosciences (2015 and 2016) Table Nippon Shinyaku Basic Information List Table Endometriosis Drugs Sales, Revenue, Price of Nippon Shinyaku (2015 and 2016) Table ObsEva Basic Information List Table Endometriosis Drugs Sales, Revenue, Price of ObsEva (2015 and 2016) Table Orphagen Pharmaceuticals Basic Information List Table Endometriosis Drugs Sales, Revenue, Price of Orphagen Pharmaceuticals (2015 and 2016) Table Philogen Basic Information List Table Endometriosis Drugs Sales, Revenue, Price of Philogen (2015 and 2016) Table PregLem Basic Information List Table Endometriosis Drugs Sales, Revenue, Price of PregLem (2015 and 2016) Table Repros Therapeutics Basic Information List Table Endometriosis Drugs Sales, Revenue, Price of Repros Therapeutics (2015 and 2016) Table Roivant Sciences Basic Information List Table Endometriosis Drugs Sales, Revenue, Price of Roivant Sciences (2015 and 2016) Table SK Chemicals Basic Information List Table Endometriosis Drugs Sales, Revenue, Price of SK Chemicals (2015 and 2016) Table Speciality European Pharma Basic Information List Table Endometriosis Drugs Sales, Revenue, Price of Speciality European Pharma (2015 and 2016) Table SYNG Pharmaceuticals Basic Information List Table Endometriosis Drugs Sales, Revenue, Price of SYNG Pharmaceuticals (2015 and 2016) Table Takeda Basic Information List Table Endometriosis Drugs Sales, Revenue, Price of Takeda (2015 and 2016) Table United Pharmaceuticals Basic Information List Table Endometriosis Drugs Sales, Revenue, Price of United Pharmaceuticals (2015 and 2016) Table ValiPharma Basic Information List Table Endometriosis Drugs Sales, Revenue, Price of ValiPharma (2015 and 2016)



To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $2900
Multi User - US $3770
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify